awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39186928-490BFE4A-291F-4E41-9FAC-D205C60E1F51
Q39186928-490BFE4A-291F-4E41-9FAC-D205C60E1F51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39186928-490BFE4A-291F-4E41-9FAC-D205C60E1F51
Intrahepatic cholangiocarcinoma: current management and emerging therapies.
P2860
Q39186928-490BFE4A-291F-4E41-9FAC-D205C60E1F51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39186928-490BFE4A-291F-4E41-9FAC-D205C60E1F51
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
90f9921bba550f4c560756234df04c5905036f91
P2860
Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors.